Skip to content
Cardiovascular healthValidation study/review3 min read

Garmin fēnix 6: VO2max estimate matched the lab, blood oxygen readings did not

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Validation of Aerobic Capacity (VO2max) and Pulse Oximetry in Wearable Technology. · Sensors (Basel, Switzerland) · 2025 · Original paper ↗

Key takeaway

In 19 apparently healthy adults, the Garmin fēnix 6 VO2max estimate agreed well with a laboratory metabolic system (30 s averaged data: MAPE 7.05%, concordance correlation 0.73), but its blood oxygen readings in 22 adults did not (concordance correlation 0.10 for combined conditions). The samples were small and only one watch model was tested.

Study design

Validation study/review

Reading basis

Published abstract

Reading focus

Reference & error

The research question

Wearables are increasingly popular and sophisticated, but independent checks of their accuracy are needed. The authors tested how accurate the Garmin fēnix 6 is at estimating VO2max and at measuring blood oxygen saturation by pulse oximetry in a general population sample.

Who and how

Validation study in apparently healthy active and sedentary adults: n = 19 for VO2max and n = 22 for pulse oximetry. For VO2max, the fēnix 6 estimate was compared with a criterion value from a metabolic system, measured during a graded exercise test and an outdoor run. For pulse oximetry, fēnix 6 readings under normoxic and hypoxic conditions were compared with a medical-grade pulse oximeter. Analysis covered descriptive statistics, error, correlation, equivalence testing and bias, with validity criteria set at a concordance correlation coefficient (CCC) above 0.7 and a mean absolute percentage error (MAPE) below 10%.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    VO2max: estimates closely matched the 15 s and 30 s averaged laboratory data. For the 30 s average, MAPE was 7.05% (criterion below 10%) and Lin's CCC was 0.73 (criterion above 0.7).
  2. 2
    Blood oxygen saturation: the watch failed to measure accurately under any condition or in the combined analysis. For combined conditions, MAPE was 4.29%, under the 10% criterion, but Lin's CCC was 0.10, far below 0.7.
  3. 3
    The authors conclude the fēnix 6 shows promise for estimating VO2max but falls short for blood oxygen, limiting its use for monitoring acclimatization and managing pulmonary diseases.

Limits & uncertainty

  1. 1
    Samples were small: 19 people for VO2max and 22 for pulse oximetry, all apparently healthy, so results may not hold in people with lung or heart disease or at other fitness levels.
  2. 2
    Only one watch model (fēnix 6) was tested; the abstract says nothing about other Garmin models or other brands.
  3. 3
    The abstract gives average error (MAPE) and agreement (CCC), not the spread of individual errors, and the CCC of 0.73 only just clears the 0.7 criterion, so some individual estimates may be well off.
  4. 4
    Pulse oximetry was compared with a medical-grade pulse oximeter, not blood samples, and the abstract does not report which oxygen levels were tested. This reading is based on the abstract only.

What to take from it

The fēnix 6 VO2max estimate looked reasonably close to laboratory values in this small sample, so it is fair to use it as a rough guide to your fitness trend. Its blood oxygen reading should not be used to make health decisions; if you have symptoms or a lung condition, rely on medical-grade measurements and your clinician.

Reading your own data

For VO2max, follow the trend from the same watch over weeks to months and compare like with like (similar runs, same settings); a single number is an estimate with an error margin like the 7.05% seen here. Treat watch blood oxygen as a rough curiosity, because this study found poor agreement with a medical oximeter, and take a low reading or symptoms to a clinician rather than relying on the watch.

How to read this evidence

Agreement is specific to the device, firmware, reference, population and setting. Correlation is not agreement, and validating a metric is not proof of diagnostic or treatment benefit.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Introduction

As wearable technology becomes increasingly popular and sophisticated, independent validation is needed to determine its accuracy and potential applications. Therefore, the purpose of this study was to evaluate the accuracy (validity) of VO2max estimates and blood oxygen saturation measured via pulse oximetry using the Garmin fēnix 6 with a general population participant pool.

Methods

We recruited apparently healthy individuals (both active and sedentary) for VO2max (n = 19) and pulse oximetry testing (n = 22). VO2max was assessed through a graded exercise test and an outdoor run, comparing results from the Garmin fēnix 6 to a criterion measurement obtained from a metabolic system. Pulse oximetry involved comparing fēnix 6 readings under normoxic and hypoxic conditions against a medical-grade pulse oximeter. Data analysis included descriptive statistics, error analysis, correlation analysis, equivalence testing, and bias assessment, with the validation criteria set at a concordance correlation coefficient (CCC) > 0.7 and a mean absolute percentage error (MAPE) < 10%.

Results

The Garmin fēnix 6 provided accurate VO2max estimates, closely aligning with the 15 s and 30 s averaged laboratory data (MAPE for 30 s avg = 7.05%; Lin's concordance correlation coefficient for 30 s avg = 0.73). However, it failed to accurately measure blood oxygen saturation (BOS) under any condition or combined analysis (MAPE for combined conditions BOS = 4.29%; Lin's concordance correlation coefficient for combined conditions BOS = 0.10).

Conclusion

While the Garmin fēnix 6 shows promise for estimating the VO2max, reflecting its utility for both individuals and researchers, it falls short in accurately measuring BOS, limiting its application for monitoring acclimatization and managing pulmonary diseases. This research underscores the importance of validating wearable technology to leverage its full potential in enhancing personal health and advancing public health research.

Sources & attribution

Validation of Aerobic Capacity (VO2max) and Pulse Oximetry in Wearable Technology.

Carrier B, Marten Chaves S, Navalta JW.

Sensors (Basel, Switzerland) · 2025-01-06

DOI: 10.3390/s25010275 ↗PubMed · 39797066 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Observational meta-analysis

Disrupted daily rest-activity rhythm is linked to higher mortality in 109,365 people

Across seven observational studies with 109,365 participants, a weaker day-night activity contrast (lower relative amplitude) was associated with higher cardiovascular mortality (hazard ratio [HR] 1.50, 95% CI 1.13 to 1.98) and all-cause mortality (HR 1.46, 95% CI 1.27 to 1.68). The evidence base is small and observational, so it cannot show that improving the rhythm lowers risk, and illness may itself disturb the rhythm.

Journal of the American Heart Association

In-depth explainersRead study →
·Trial meta-analysis

Five exercise types lowered resting blood pressure, isometric training the most

Pooling 270 randomised trials with 15,827 participants, aerobic, resistance, combined, interval and isometric training all lowered resting blood pressure compared with non-intervention controls (P<0.001 for each), with the largest fall for isometric training: 8.24 mm Hg systolic and 4.00 mm Hg diastolic. The ranking between modes is partly indirect and the trials differ, so it is not a personal prescription.

British Journal of Sports Medicine

In-depth explainersRead study →
·Randomised trial

A salt substitute lowered stroke, major cardiovascular events and death in rural China

In 20,995 people in 600 rural Chinese villages who had a history of stroke or were 60 or older with high blood pressure, a salt substitute (75% sodium chloride, 25% potassium chloride) lowered the stroke rate versus regular salt over a mean 4.74 years: 29.14 versus 33.65 events per 1000 person-years (rate ratio 0.86, 95% CI 0.77 to 0.96; P = 0.006). Death was also lower (rate ratio 0.88) and serious hyperkalemia events were not significantly higher, but the trial was open-label and set in rural China.

The New England Journal of Medicine

In-depth explainersRead study →
·Validation study/review

Apple Watch irregular-pulse alerts were rare; 34% of those tested had atrial fibrillation

Among 419,297 Apple Watch users with no known atrial fibrillation (AF), 0.52% received an irregular-pulse alert, and 34% of the 450 who returned a usable ECG patch had AF (97.5% CI 29 to 39). Alerts that coincided with patch recording matched AF with a positive predictive value of 0.84 (95% CI 0.76 to 0.92), but only 20.8% of alerted people returned a patch and nobody without an alert was monitored, so a quiet watch does not rule AF out.

The New England Journal of Medicine

In-depth explainersRead study →
Cardiovascular health →